Large Market, Small Joint: Examining Growth, Innovations, and M&A in the Orthopedic Foot and Ankle Market

article image
ARTICLE SUMMARY:

Robust innovation in foot and ankle devices is sustaining revenue growth and M&A activity, but in a highly consolidated market, the long-term outlook for new players and ongoing activity is uncertain. By Masha Dumanis, Health Advances.

To those in the orthopedics industry, it is no secret that foot and ankle is currently one of the hottest segments with one of the highest CAGRs—outpacing darlings of the last decade like sports medicine and shoulder replacement. Some of the most vibrant subsegments, such as bunions, hammertoe, and nonfracture ankle treatments, are growing at 9%. The rapid rate of innovation is enabling a dizzying pace of product and company launches in this space, creating challenges for clinicians in discerning the clinical value of new products from their marketing pizzazz.

The emergence of stand-alone extremity firms, and even more focused foot and ankle companies, in the last few years has led larger, diversified players with portfolio gaps on a rapid M&A hunt.

×

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?


Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.

All-Access

Questions?

We're here to help! Please contact us at: